RB
Robert Burns HC Wainwright & Co. Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Relay Therapeutics
RLAY
$690M
| $4 | $14 |
250%
upside
| Buy | 9 days ago |
|
|
BCAX
2
Bicara Therapeutics Inc. Common Stock
BCAX
$658M
| $12.06 | $40 |
232%
upside
| Buy | 13 days ago |
|
3
Cullinan Oncology
CGEM
$408M
| $6.91 | $24 |
247%
upside
| Buy | 14 days ago |
|
4
BioNTech
BNTX
$24.9B
| $103.50 | $136 |
31%
upside
| Buy | 21 days ago |
|
5
Oric Pharmaceuticals
ORIC
$1.05B
| $10.77 | $19 |
76%
upside
| Buy | 21 days ago |
|
6
ArriVent BioPharma
AVBP
$792M
| $19.52 | $42 |
115%
upside
| Buy | 23 days ago |
|
7
Exelixis
EXEL
$10.1B
| $37.38 | $46 |
23%
upside
| Buy | 23 days ago |
|
8
Y-mAbs Therapeutics
YMAB
$389M
| $8.57 | $8.60 |
0%
upside
| Neutral | 29 days ago |
|
9
Cogent Biosciences
COGT
$1.81B
| $12.94 | $21 |
62%
upside
| Buy | 29 days ago |
|
10
Nurix Therapeutics
NRIX
$697M
| $9.12 | $34 |
273%
upside
| Buy | 1 month ago |
|
11
Zymeworks
ZYME
$1.07B
| $14.08 | $13 |
8%
downside
| Neutral | 2 months ago |
|
|
TLX
12
Telix Pharmaceuticals Limited American Depositary Shares
TLX
$3.04B
| $9.08 | $23 |
153%
upside
| Buy | 2 months ago |
|
13
Enliven Therapeutics
ELVN
$1.19B
| $20.01 | $48 |
140%
upside
| Buy | 2 months ago |
|
14
Revolution Medicines
RVMD
$7.28B
| $38.95 | $72 |
85%
upside
| Buy | 3 months ago |
|
15
Tango Therapeutics
TNGX
$760M
| $6.83 | $13 |
90%
upside
| Buy | 4 months ago |
|
16
ADC Therapeutics
ADCT
$382M
| $3.40 | $8 |
135%
upside
| Buy | 5 months ago |
|
17
Perspective Therapeutics
CATX
$263M
| $3.54 | $10 |
182%
upside
| Buy | 5 months ago |
|
18
Nuvation Bio
NUVB
$1.17B
| $3.42 | $10 |
192%
upside
| Buy | 5 months ago |
|
19
CytomX Therapeutics
CTMX
$346M
| $2.10 | $11 |
424%
upside
| Buy | 3 years ago |
|
|
AUTL
20
Autolus Therapeutics
AUTL
$386M
| $1.45 | $13 |
797%
upside
| Buy | 4 years ago |
|